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The cyclic heptapeptide, microcystin-LR, inhibits protein phosphatases 1(PPl) and 2A (PPZA) with K, values below 0.1 nM. Protein phosphatase 
2B is inhibited lOOO-fold less potently, while six other phosphatases and eight protein kinases tested are unaffected. These results are strikingly 
similar to those obtained with the tumour promoter okadaic acid. We establish that okadaic acid prevents the binding of microcystin-LR to PPZA, 
and that protein inhibitors 1 and 2 prevent the binding of microcystin-LR to PPI. We discuss the possibility that inhibition of PPl and PPZA 
accounts for the extreme toxicity of microcystin-LR, and indicate its potential value in the detection and analysis of protein kinases and 
phosphatases. 
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1. INTRODUCTION 
Members of the cyanobacterial genera, Microcystis, 
Oscillatoria and Anabaena produce cyclic peptides, 
termed microcystins, which are potent hepatotoxins 
[ 1,2]. These substances are responsible for the deaths of 
fish, birds, wild animals and agricultural livestock in 
many countries where freshwaters contain toxic cyano- 
bacterial blooms, and adverse effects of the toxins on 
human health have been recognised [3,4]. Microcystins 
are cyclic heptapeptides with the basic structure 
cyclo(D-Ala-L-X-erythro-&methyl-D-iso-Asp-L-Y- 
Adda-D-iso-Glu-N-methyldehydro-Ala), where L-X 
and L-Y represent variable L-amino acid residues and 
Adda is the ,&amino acid, 3-amino-9-methoxy-2,6,8- 
trimethyl-lo-phenyldeca-4,6-dienoic acid [5,6]. Micro- 
cystin-LR, in which the two variable amino acids are 
leucine and arginine (Fig. l), is the most commonly 
found variant of the nine microcystins recognised to 
date. 
bleb formation and loss of microvilli, with a major 
reorganisation of microfilaments as determined by elec- 
tron microscopy and fluorescent staining of actin 
[lo-121. 
Oral and intraperitoneal administration of the 
microcystins to mammals causes extensive loss of 
hepatic lobular and sinusoidal architecture with 
hepatocyte necrosis and hepatic haemorrhage. l-2pg of 
microcystin-LR constitutes a lethal intraperitoneal dose 
to mice, with most of the toxin accumulating in the 
liver, and death occurring in about 60 min from 
haemodynamic shock and heart failure [1,2,7-g]. At 
the cellular level, microcystin-LR causes rapid, charac- 
teristic deformation, e.g. hepatocyte plasma membrane 
Recently, we learned from Dr R.E. Moore [I31 that 
H. Fujiki and co-workers (National Cancer Center, 
Tokyo) have found that microcystin-LR is an inhibitor 
of protein phosphatases 1and 2A (PPl, PP2A), two of 
the major phosphatases in eukaryotic cells that 
dephosphorylate serine and threonine residues [ 14,151. 
Here, we demonstrate that microcystin-LR is a highly 
specific and potent inhibitor of PPl and PP2A from 
phyla as diverse as mammals, protozoa and higher 
plants, and that it inhibits these enzymes in a remark- 
ably similar manner to okadaic acid, a potent tumour 
promoter that is also the toxin responsible for diarrhetic 
shellfish poisoning (see [16] for a review). We present 
kinetic evidence which demonstrates that the binding of 
okadaic acid to PP2A prevents its interaction with 
microcystin-LR, and that microcystin is unable to bind 
to PPI in the presence of inhibitor-l or inhibitor-2, two 
thermostable proteins that inhibit PPI specifically. 
2. MATERIALS AND METHODS 
2.1. Materials 
Correspondence address: C. MacKintosh, Department of Biochemis- 
try, University of Dundee, Dundee DDl 4HN, Scotland 
The catalytic subunits of PPl and PPZA [17] (Mr D. Schelling), 
PPZC [18] (Dr C. McGowan), inhibitor-l (Miss L. MacDougall) and 
inhibitor-2 (Dr M. Hubbard) [19] were purified to homogeneity from 
rabbit skeletal muscle and provided by other members of the Protein 
Phosphorylation Group at Dundee. PPI and PPM in extracts of the 
protozoan Paramecium tetraurelia were separated by 
chromatography on heparin-Sepharose [20]. PPZB from bovine brain 
(calcineurin) was a gift from Dr Claude Klee, National Cancer In- 
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Fig. 1. Structure of microcystin-LR. Abbreviations: Masp, ,& 
methylaspartic acid; Mdha, N-methyldehydroalanine; Adda, 
3-amino-9-methoxy-2,6,8-trimethyl-lO-phenyldeca-4,6-dienoic acid. 
stitute, NIH, USA. Potato acid phosphatase and calf intestinal 
alkaline phosphatase were purchased from Boehringer. Okadaic acid 
was a gift from Dr Y. Tsukitani, Fujisawa Chemical Company, 
Japan. 
2.2. Isolation and analysis of microcystins 
Microcystin-LR was purified from Microcystis aeruginosa har- 
vested from Rutland Water, England. The microcystin-LR was iso- 
lated and purified by high-performance liquid chromatography essen- 
tially as described [21,22]. The toxin was dissolved in 10% methanol 
to give a 0.4 mM solution and its concentration determined by amino 
acid analysis using a Water’s PICOTAG system. Hydrolysis in 6 N 
HCI for 3 h at 150°C was essential to obtain complete peptide bond 
cleavage. Microcystin-LR was diluted in 50 mM Tris-HCl, pH 7.0 
(4°C) containing 0.03% Brij 35 and retained its phosphatase inhibi- 
tory activity for at least a month at concentrations as low as 0.01 nM. 
2.3. Preparation of cell extracts 
Extracts were prepared from rat liver 1231, Brassica napus (rape) 
seeds [24], and Escherichia coli [25] as described. Extracts were also 
prepared from nine strains of cyanobacteria (provided by Dr P. 
Rowell, Dept of Biological Sciences, University of Dundee) by sonica- 
tion in 100 mM Hepes, pH 7.4,0.1% (v/v) 2-mercaptoethanol, 2 mM 
EDTA, 1 mM benzamidine, 1 mM phenylmethylsulphonyl fluoride, 
and freed from low-molecular-mass substances by gel filtration on 
Sephadex G50 equilibrated in the same buffer. 
2.4. Phosphatase assays 
PPl and PP2A were assayed in the absence of divalent cations us- 
ing 10 pM ‘*P-1abelled glycogen phosphorylase [17], PPZB in the 
presence of 1 mM MnClz using 1 PM [“Plphosphorylase kinase [26] 
and PP2C in the presence of 10 mM MgClz using 6 PM [“‘Plcasein 
[18]. One unit of protein phosphatase was that amount which catalys- 
ed the dephosphorylation of 1 pmol of substrate in 1 min. PPl and 
PPZA were also assayed with other substrates where specified. The 
bacteriophage h protein phosphatase (orf 221) was assayed in the 
presence of 1 mM MnC12 and [“Plcasein, using extracts from phage 
hgtlO-infected E. coli prepared just prior to cell lysis 1251. Alkaline 
and acid phosphatases were assayed at 37°C using 0.5 mM para- 
nitrophenyl phosphate at pH 8 and pH 5, respectively. 
Protein tyrosine phosphatase activity was assayed in NP40 lysates 
of actively growing rat fibroblasts using 32P-labelled poly (Glu,Tyr) 
(4: 1) phosphorylated by a protein tyrosine kinase purified from 
MDCK cells. These experiments were performed by Dr E. Ulug and 
Dr S. Courtneidge, EMBL, Heidelberg. 
2.5. Isolation and assay of protein kinases 
The catalytic subunit of cyclic AMP-dependent protein kinase from 
bovine cardiac muscle (Dr C. Smythe), phosphorylase kinase (Mr D. 
Schelling), casein kinases 1 and 2 (Dr A. Lavoinne and Miss S. 
Nakielny) and glycogen synthase kinase 3 (Dr C. Smythe) from rabbit 
skeletal muscle, the multifunctional calmodulin-dependent protein 
kinase from rat brain (Dr D.G. Hardie) and the AMP-activated pro- 
tein kinase from rat liver (Mr John Weekes) were provided by other 
colleagues in the Protein Phosphorylation Group at Dundee. Protein 
kinase C from rat brain was a gift from Dr Alastair Aitken, National 
Institute for Medical Research, London. Each enzyme was assayed 
using glycogen synthase (0.5 mg/ml, 4 rM) as substrate by standard 
procedures [27]. Phosphorylation was limited to <0.15 mol 
phosphate incorporated per mol glycogen synthase subunit, to ensure 
that initial rate conditions were met. 
3. RESULTS 
The dephosphorylation of glycogen phosphorylase 
by the purified catalytic subunits of PPl and PP2A 
from rabbit skeletal muscle was potently inhibited by 
microcystin-LR, 50% inhibition (I&) of either enzyme 
occurring at - 0.1 nM microcystin-LR, when assays 
were performed at phosphatase concentrations of 0.2 
mU/ml (Fig. 2). This compares with I& values of 10 
nM (PP 1) and 0.1 nM (PP2A) for inhibition by okadaic 
acid under the same conditions [28]. Similar I& values 
for PPI and PP2A were obtained using [32P]phospho- 
rylase kinase, while with [32P]casein, a specific 
substrate for PP2A [29], the ICSO was 0.2 nM (data not 
shown). 
The I& for microcystin-LR is similar to the concen- 
trations of PPl and PP2A in the assays, demonstrating 
that the toxin-phosphatase interactions are extremely 
strong. Consistent with essentially stoichiometric bin- 
ding, the ICSO values for inhibition of PPl and PP2A 
depended on the phosphatase concentration in the 
assays (Fig. 3), the effect being most pronounced for 
PP2A (Fig. 3). This would be expected, since the molar 
concentration of PPZA in the assays is lo-fold higher 
than PPl (the specific activity of PP2A towards 
glycogen phosphorylase being - IO-fold lower than 
PPl [30]). Extrapolation to zero phosphatase concen- 
trations of the data in Fig. 3 (and other experiments) in- 
dicates that the Ki for PPl is about 0.06 nM, while for 
PP2A it is even lower, probably below 0.01 nM. 
The amino acid sequences of PPl and PP2A show 
50% identity in the catalytic domain (reviewed in 
[ 14,151). The Ca’+/calmodulin-regulated protein 
phosphatase (PP2B) is a member of the same gene fami- 
ly, but despite showing 40% identity to PPl or PP2A in 
the catalytic domain (reviewed in [ 15]), it is far less sen- 
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Fig. 2. Inhibition of different protein phosphatases by microcystin- 
LR. The catalytic subunits of PPl (0) and PPM (0) were assayed at 
0.21 and 0.23 mu/ml, respectively, using 32P-labelled glycogen 
phosphorylase as substrate, PP2B (v) at 0.04 mU/ml using 
[“Plphosphorylase kinase and PP2C (v) at 0.02 mu/ml using 
sitive to okadaic acid (I& - 5 /IM) [31]. Fig. 2 shows 
that microcystin-LR inhibits PP2B, but with an I& 
value (0.2 ,uM) at least lOOO-fold higher than that 
observed with PPl or PPZA. 
PP2A activity in the ciliated protozoan Paramecium 
tetraurelia is unique among eukaryotic cells so far ex- 
amined in being unaffected by okadaic acid [20], while 
a protein phosphatase encoded in the genome of 
bacteriophage h (orf221) that is structurally related to 
PPl/PPZA is also unaffected by this tumour promoter 
[25]. Neither of these phosphatases was affected by 
microcystin-LR at concentrations as high as 4 PM (data 
not shown). In contrast, PPl activity in Paramecium, 
which is inhibited by okadaic acid [20], was inhibited by 
microcystin-LR similarly to mammalian PPl (I& = 
0.13 nM). 
The specificity of microcystin-LR was tested by ex- 
amining its ability to inhibit phosphatases that are 
structurally unrelated to PPUPP2A. At a concentra- 
tion of 4pM, microcystin-LR (like okadaic acid) had no 
effect on the activity of protein phosphatase 2C 
(Fig. 2), while at 1 FM it had no effect on potato acid 
phosphatase, calf intestinal alkaline phosphatase, and 
protein tyrosine phosphatase activity towards 32P- 
labelled poly (Glu,Tyr) in extracts of rat fibroblasts. 
Similarly, microcystin-LR (4/cM) was without effect on 
the following eight protein kinases; cyclic AMP- 
dependent protein kinase, the multifunctional cal- 
modulin-dependent protein kinase, phosphorylase 
kinase, protein kinase C, the AMP-activated protein 
kinase, casein kinase 1, casein kinase 2 and glycogen 
synthase kinase 3. 
In view of the striking similarities in the inhibition by 
microcystin-LR and okadaic acid, it was of interest to 
determine whether these toxins bind to the same site on 
PPl/PP2A. However, because both toxins are ‘tight- 
binding inhibitors’, standard Michaelis-Menten 
0 
100 T 
z 80 
E 
E 60 
$ 40 
Y 
20 
0 1 
0 ooo4 004 w 4.0 
microcystin-LR hM) 
Fig. 3. Inhibition of the purified catalytic subunits of PPl and PP2A 
from rabbit skeletal muscle by microcystin-LR. PPl was assayed with 
glycogen phosphorylase at 0.05 mU/ml (o), 0.41 mu/ml (0) and 2.3 
mu/ml (v). PPZA was assayed with the same substrate at 0.05 
mU/ml (o), 0.25 mU/ml (0) and 0.75 mu/ml (v). 
kinetics cannot be used to solve this problem. The in- 
hibition of PPl by microcystin-LR was therefore ex- 
amined in the presence of a large molar excess of PP2A 
which had first been inactivated by incubation with 
NaF and PPr (see legend to Fig.4). This caused an in- 
crease in the I& for microcystin-LR (Fig. 4), in- 
dicating that PP2A, although inactive, could still bind 
this toxin. However, the increase in ICSO was abolished 
by preincubating inactive PP2A with okadaic acid 
(Fig. 4), using a concentration in the assay (1 nM) suffi- 
cient to form a complex with PP2A, but too low to in- 
activate PP 1 [28]. These experiments demonstrated that 
the binding of okadaic acid to PP2A prevented the 
subsequent binding of microcystin-LR. 
We next tested the effect of inhibitor proteins 1 and 
2, which inhibit PPl specifically (reviewed in [14]), on 
the subsequent binding of microcystin-LR to PPl. 
PP2A was assayed in the presence of excess PPl using 
a substrate ([32P]casein) that is selective for PP2A [29]. 
The presence of PPI caused a 3-fold increase in the I& 
for inhibition of PPZA by microcystin-LR (Fig. 5), 
which was abolished by preincubating PPl with either 
inhibitor-l or inhibitor-2 (Fig. 5). These experiments 
demonstrated that the binding of inhibitors 1 or 2 to 
PPl prevented the binding of microcystin-LR. 
The free catalytic subunits of PPl and PP2A do not 
normally exist in vivo, but are complexed to regulatory 
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Fig. 4. Okadaic acid prevents the interaction of microcystin-LR with 
PP2A. The purified catalytic subunit of rabbit skeletal muscle PPM 
(0.6 ml, 60 mU/ml) was completely inactivated by incubation for 1 h 
on ice in 50 mM Tris-HCl, pH 7.0 (4”C), 0.1 mM EGTA, 0.1% 
2-mercaptoethanol (solution A) containing 100 mM NaF, 5 mM 
sodium pyrophosphate and 1 mg/ml bovine serum albumin, and then 
passed through a 25 x 1.2 cm column of Sephadex G-50 Superfine 
equilibrated in solution A to remove fluoride and pyrophosphate. The 
inhibition of the catalytic subunit of PPI (0.03 mU/ml) by 
microcystin-LR was then examined using 32P-labelled glycogen 
phosphorylase as substrate, in the presence (rf and absence (e) of 
the GSO eluate (diluted a further six-fold in the assay). The open 
circles show the effect of preincubating the G50 eluate with 6 nM 
okadaic acid (diluted to 1 nM okadaic acid in the assay, a concentra- 
tion that does not inhibit PP1 [28]). Similar results were obtained in 
three separate xperiments. 
and/or targetting subunits (reviewed in (14,151). Fig. 6 
demonstrates that the active forms of PPl and PP2A in 
dilute extracts of rat liver or Brassica napus (rape) seeds 
are inhibited by microcystin-LR with similar potency to 
the free catalytic subunits. PPl and PP2A in other 
plant extracts (carrot cells, wheat leaf and pea leaf) were 
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Fig. 5. inhibitor-l (I-l) and inhibitor-2 (i-2) prevent he interaction of 
microcystin-LR with PPI. Inhibition of the catalytic subunit of rabbit 
skeletal muscle PPZA (0.14 mU/ml) was examined using [32P]casein 
as substrate in the presence (v) and absence (0) of the PPl catalytic 
subunit (2.9 mu/ml). The open circles show the effect of prein- 
cubating PPl with either I-l or I-2 (final concentration 0.25 /rM in 
assay). Casein is a selective substrate for PPM, PPl only accounting 
for 12% of the casein phosphatase activity in the absence of I-1 or f-2, 
and for none for the activity in the presence of these inhibitors. 
Similar results were obtained in three separate xperiments. 
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Fig. 6. The active high-mol~ular-mass forms of PPI and PPM in 
m~rn~ian and plant extracts are inhibited by mi~rocystin-LR with 
similar potency to the catalytic subunits. Rat livers and B. napus seeds 
were frozen in liquid nitrogen, powdered and extracts prepared as 
described [23,24]. The extracts were then assayed at a @IO-fold dilu- 
tion (liver extracts, V) and 225-fold dilution (B. nupus extracts, 0) 
using glycogen phosphorylase as substrate. PPl activity was 
measured in the presence of 1 nM okadaic acid to inhibit PP2A, and 
PPM after preincubation with 0.25 CM inhibitor-2 to inactivate PPl 
[28]. The concentrations in the assays were 0.08 mU/ml (liver PPl), 
0.07 mU/ml (liver PPZA), 0.065 mu/ml (B. napus PPl) and 0.053 
mU/ml (S. napus PPZA). The 1Cs0 values are similar to those obtain- 
ed with the purified catalytic subunits of PPl and PPM (both 0.06 
mU/mI) from rabbit skeletal muscle (0). Similar results were obtain- 
ed in two experiments using different liver and B. nupus extracts. 
inhibited by microcystin-LR in a similar manner (data 
not shown). The slightly higher ICSO values for the 
native enzymes (Fig. 6) are probably explained by their 
higher molar concentrations in the assays, the native en- 
zymes having lower specific activities than the catalytic 
subunits [ 141. 
4. DISCUSSION 
The results presented in this paper establish that 
microcystin-LR is a highly specific inhibitor of PPl and 
PP2A and that this toxin inhibits these enzymes in a 
remarkably similar manner to the CM polyketal fatty 
acid okadaic acid ([30], reviewed in [ 161). Thus, both in- 
hibitors inhibit PPZA more potently than PPl, inhibit 
PP2B at least lOOO-fold less strongly, do not inhibit the 
structurally related protein phosphatase of bacterio- 
phage A or the type 2A-like protein phosphatases of 
Paramecium tetraurelia, and do not inhibit any other 
protein phosphatase or protein kinase that has been 
tested. Like okadaic acid, microcystin-LR inhibits plant 
and mammalian PPl and PP2A in an identical manner 
(Fig. 6, [24]), an observation explained by the extreme 
structural conservation of these phosphatase catalytic 
subunits (R.W. MacKintosh, personal communica- 
tion). 
Our kinetic studies (Fig. 4) indicate that prior bin- 
ding of okadaic acid to PP2A prevents it from interac- 
ting with micro~ystin-LR, suggesting that, despite their 
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quite different chemical compositions, these toxins may 
well bind to the same site(s) on PPVPP2A. Intriguing- 
ly, the thermostable proteins inhibitor-l and inhi- 
bitor-2, which inhibit PPl specifically, also prevent the 
binding of microcystin-LR (Fig. 4). Thus all known 
substances that are potent inhibitors of PPlIPP2A may 
exert their effects by interacting at the same site on these 
enzymes. 
Microcystin-LR is lethal to mice when l-2 ,ug (1-2 
nmol) are injected intraperitoneally, about 75% of the 
injected toxin accumulating in the liver. Since the in- 
tracellular concentrations of PPl and PP2A in mam- 
malian tissues are both about 1 PM, an adult mouse 
liver weighing about a gram would contain -0.5 nmol 
of each enzyme. These observations are consistent with 
the possibility that phosphat~e inhibition may underlie 
the extreme toxicity of microcystin-LR. PPl and PP2A 
are involved in dephosphorylating regulatory proteins 
that control many cellular functions (reviewed in 
[14,15]), and it is not surprising that their complete in- 
activation would rapidly be lethal. It is even conceivable 
that inhibition of PPl and PP2A might explain, in part, 
why reduced plant and animal species diversity is a com- 
mon feature of waters containing toxic cyanobacterial 
blooms. 
The presence of high levels of microcystin-LR in 
Microcystis aeruginosa raises the question of the 
biological function of this toxin which is present at high 
levels in hepatotoxic cyanobacteria, We have examined 
nine different strains of marine and freshwater 
cyanobacteria for enzymatic activities that resemble 
PPI and PP2A, but failed to find any with significant 
activity towards glycogen phosphorylase (a specific 
substrate for PPl and PP2A in eukaryotic cells). This is 
consistent with the absence of these enzymes in other 
prokaryotes, such as E=. coli 1251, and suggests that 
cyanobacteria do not contain PPI- and PP2A-like ac- 
tivities that have evolved resistance to microcystins. 
Since most of these strains of cyanobacteria do not syn- 
thesise toxins related to microcystins, it is unlikely that 
PPl and PP2A-like activities were present, but masked 
by the presence of related cyclic heptapeptides. 
Okadaic acid is becoming an extremely useful 
substance for the study of protein kinases, protein 
phosphat~es and cellular processes that are controlled 
by phosphorylation. At a concentration of 1 nM it can 
be used as a specific inhibitor of PP2A in dilute tissue 
extracts, while above 1 PM it inhibits both PPl and 
PP2A. This allows the quantitation in cell extracts of 
other protein phosphatases with similar substrate 
specificities, such as PPZC [28]. Furthermore, the 
routine inclusion of okadaic acid in protein kinase 
assays is to be recommended, since it can aid the detec- 
tion of enzymes whose activities were previously mask- 
ed by the presence of high levels of cont~inating pro- 
tein phosphatase activity [31]. Although microcystin- 
LR cannot be used to discriminate between PPI and 
PP2A, it should be even more valuable than okadaic 
acid for the other purposes mentioned above, because it 
inhibits PPI at a much lower concentration and is easier 
to isolate than okadaic acid. We have established that 
PPZC activity can be quantitated in dilute mammalian 
extracts if 10 nM microcystin is included in the assays 
(C. MacKintosh, unpublished experiments). 
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NOTE ADDED IN PROOF 
After submission we noticed a paper by Runnegar, M.T.C., Andrews, J., Gerdes, R.G. and Falconer, I.R. [(1987) 
Toxicon 25, 1235-12391, who observed a time- and dose-dependent activation (phosphorylation) of phosphoryl~e in 
hepatocytes in response to a microcystin from M. ~e~~g~~o~~. This is consistent with its action as a protein 
phosphatase inhibitor. 
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